Published in Am J Respir Crit Care Med on September 17, 2009
Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2011) 1.01
Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2013) 0.99
Update in asthma 2009. Am J Respir Crit Care Med (2010) 0.96
Pathways analysis of molecular markers in chronic sinusitis with polyps. Otolaryngol Head Neck Surg (2011) 0.80
Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis. Eur Arch Otorhinolaryngol (2010) 0.77
Expression of semaphorin 3A and neuropilin 1 in asthma. J Korean Med Sci (2013) 0.77
Correlation analysis of STAT3 and VEGF expression and eosinophil infiltration in nasal polyps. Eur Arch Otorhinolaryngol (2014) 0.77
Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS One (2014) 0.77
DCBLD2 gene variations correlate with nasal polyposis in Korean asthma patients. Lung (2012) 0.76
Otolaryngology-head and neck surgery at Johns Hopkins: The first 100 years (1914-2014). Laryngoscope (2015) 0.75
Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics. J Korean Med Sci (2012) 0.75
Potential application of injectable chitosan hydrogel treated with siRNA in chronic rhinosinusitis therapy. Mol Med Rep (2015) 0.75
Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor. Int J Otolaryngol (2011) 0.75
The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis. Eur Arch Otorhinolaryngol (2014) 0.75
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol (2007) 15.45
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem (1994) 6.18
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem (1992) 4.92
Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg (2003) 4.63
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J (2001) 3.92
Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem (1998) 3.78
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med (2004) 3.64
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem (1995) 3.30
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem (1994) 2.87
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
The airway epithelium: structural and functional properties in health and disease. Respirology (2003) 2.73
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis (1983) 2.37
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci U S A (1990) 2.31
Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol (2001) 2.12
p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem (1998) 2.07
Current estimates from the National Health Interview Survey, 1995. Vital Health Stat 10 (1998) 1.95
The airway epithelium is central to the pathogenesis of asthma. Allergol Int (2008) 1.88
Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J Biol Chem (2001) 1.71
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol (2001) 1.67
Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. Am J Respir Cell Mol Biol (2005) 1.56
Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem (1997) 1.52
The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope (2009) 1.46
The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy (1999) 1.43
A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells. Br J Cancer (2005) 1.39
Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol (2006) 1.33
Epithelial damage and response. Clin Exp Allergy (2000) 1.27
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy (2003) 1.24
Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol (2002) 1.23
Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest (1992) 1.21
Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda) (2005) 1.19
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J (2002) 1.19
Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. Medicina (Kaunas) (2008) 1.18
A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol (1988) 1.14
Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol (2005) 1.09
Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol (2007) 1.09
Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol (2001) 1.08
Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax (2000) 1.06
The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc (1997) 1.04
The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol (2006) 1.02
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood (2003) 0.99
Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am J Respir Cell Mol Biol (1995) 0.98
Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies. J Allergy Clin Immunol (2008) 0.97
Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol (2000) 0.96
Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol (2003) 0.95
Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. J Immunol (2006) 0.93
Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell Signal (2001) 0.92
Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol (2002) 0.91
Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol (2004) 0.90
Histopathological observations in chronic maxillary sinusitis. Acta Otolaryngol (1991) 0.89
Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med (2003) 0.89
Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope (2008) 0.88
Role of platelet-derived growth factor in airway remodeling in rhinosinusitis. Am J Rhinol Allergy (2009) 0.87
Histopathological features of nasal polyps with asthma association: an immunohistochemical study. Am J Rhinol (2004) 0.87
Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol (2005) 0.86
Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates. Int Arch Allergy Immunol (2009) 0.84
Vascular endothelial growth factor and children featuring nasal polyps. Int J Pediatr Otorhinolaryngol (2006) 0.84
Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope (1996) 0.83
Expression analysis of VEGFA, FGF2, TGFbeta1, EGF and IGF1 in human nasal polyposis. Oncol Rep (2008) 0.83
Molecular profile of the antrochoanal polyp: up-regulation of basic fibroblast growth factor and transforming growth factor beta in maxillary sinus mucosa. Am J Rhinol (2006) 0.83
Vascular permeability factor/vascular endothelial growth factor in nasal polyps. Acta Otolaryngol Suppl (2000) 0.82
Vascular endothelial growth factor in nasal polyps: a comparison of asthmatic and non-asthmatic patients. Clin Otolaryngol Allied Sci (2004) 0.81
Identification of selective basophil chemoattractants in human nasal polyps as insulin-like growth factor-1 and insulin-like growth factor-2. J Immunol (2004) 0.79
Transient expression of insulin-like growth factor I immunoreactivity by vascular cells during angiogenesis. Exp Mol Pathol (1989) 0.77
Retracted Expression of concern: Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med (2009) 2.28
DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol (2012) 1.34
Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury. PLoS One (2009) 1.24
Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis. Proc Am Thorac Soc (2009) 1.22
T cells enhance gold nanoparticle delivery to tumors in vivo. Nanoscale Res Lett (2011) 1.17
Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis (2004) 1.15
Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol (2011) 1.09
Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials (2011) 1.04
Zinc(II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line. Biometals (2010) 1.04
Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg (2005) 1.01
Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies. J Allergy Clin Immunol (2008) 0.97
Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol (2004) 0.96
ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport (2002) 0.88
Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins. Neurobiol Dis (2003) 0.88
Development and pilot-testing of a feasible, reliable, and valid operative competency assessment tool for endoscopic sinus surgery. Am J Rhinol Allergy (2009) 0.88
Fabrication of micropatterned polymeric nanowire arrays for high-resolution reagent localization and topographical cellular control. Nano Lett (2015) 0.87
Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies. Neurobiol Dis (2003) 0.85
Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia. Glia (2002) 0.85
Video-based assessment of operative competency in endoscopic sinus surgery. Am J Rhinol Allergy (2009) 0.84
Constitutive expression of vascular endothelial cell growth factor (VEGF) gene family ligand and receptors on human upper and lower airway epithelial cells. Int Forum Allergy Rhinol (2014) 0.82
Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment. Brain Res (2009) 0.80
Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab. Otolaryngol Head Neck Surg (2013) 0.79
Cigarette smoke inhibits nasal airway epithelial cell growth and survival. Int Forum Allergy Rhinol (2012) 0.77
Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition. J Immunother (2017) 0.75
Increased Levels of Dickkopf 3 in the Aqueous Humor of Patients With Diabetic Macular Edema. Invest Ophthalmol Vis Sci (2016) 0.75